Company / Total Assets
Cytokinetics Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.4B
FY2025
5-year range
$824.3M / $1.4B
FY2021-FY2025
Trend
+1.6%
vs FY2024
Sector context
#57 of 214
Health Care
What the data says
At $1.4B, Cytokinetics's total assets ranks #57 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $170M in FY2016 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +21.7%.
Improved from $824M to $1.4B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
#57 of 214 in Health CareTop 27% of 214This company $1.4B Sector average $7.5B
▼
-80.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.7%, indicating consistent growth.
- In FY2025, total assets increased 1.6% year-over-year.
- Ranks #57 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +1.6% |
| FY2024 | $1.4B | +70.0% |
| FY2023 | $824.3M | -18.8% |
| FY2022 | $1.0B | +20.6% |
| FY2021 | $841.3M | +57.6% |
| FY2020 | $533.8M | +84.2% |
| FY2019 | $289.8M | +37.2% |
| FY2018 | $211.2M | -28.4% |
| FY2017 | $294.8M | +73.3% |
| FY2016 | $170.1M | +47.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026